DAYVIGO 10 mg/1
lemborexant · TABLET, FILM COATED · Eisai Inc.
No Recall History
Plain English
DAYVIGO is a tablet, film coated containing lemborexant at 10 mg/1, taken oral. Manufactured by Eisai Inc..
Key Facts
- Brand Name
- DAYVIGO
- Generic Name
- lemborexant
- NDC Code (Product)
62856-410- Manufacturer
- Eisai Inc.
- Strength
- 10 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA212028
- Drug Class
- Orexin Receptor Antagonist [EPC]
- Marketing Start
- 04/07/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective298 reports
off label use176 reports
suicide attempt138 reports
somnolence135 reports
condition aggravated122 reports
suicidal ideation122 reports
fall98 reports
headache87 reports
nausea86 reports
dizziness84 reports
Frequently Asked Questions
What is DAYVIGO used for?
DAYVIGO contains lemborexant. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is DAYVIGO a controlled substance?
Yes, DAYVIGO is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for DAYVIGO?
The generic name for DAYVIGO is lemborexant. There are no other listed brand versions of lemborexant.
What is the NDC code for DAYVIGO 10 mg/1?
The NDC (National Drug Code) for DAYVIGO 10 mg/1 is 62856-410, listed by Eisai Inc..
Other DAYVIGO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)